(CNW) $207B Market Shift: The Race for Fast Track Approval in Oncology

In 2025 alone, the agency issued over 50 oncology approvals([1]) , but the real story is the aggressive pivot toward targeted therapies for high-unmet-need solid tumors. That momentum has accelerated ...

The $71 Billion Cancer Shift: Why The FDA Is Speeding Up

Equity-Insider.com News Commentary – The market is waking up to a $71 billion reality[1]. We are seeing a decisive move away ...
The Malaysian Reserve

$207B Market Shift: The Race for Fast Track Approval in Oncology

Issued on behalf of Oncolytics Biotech Inc.VANCOUVER, BC, Feb. 5, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary – The FDA isn't just approving ...

Big Pharma’s $170B Panic: Why Capital Is Rotating to Clinical Stage Oncology

Baystreet.ca News Commentary – The global oncology therapeutics market reached $164.2 billion in 2025 and is projected to hit $285.4 billion by 2030[1]; it signaled a massive ...
KVIA

10 European cities for US students in 2026

HousingAnywhere reports on 10 top European cities for US students in 2026, blending education, culture, and career opportunities.